✦ LIBER ✦

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age

✍ Scribed by Susanna Esposito; Alessandro Lizioli; Annalisa Lastrico; Enrica Begliatti; Alessandro Rognoni; Claudia Tagliabue; Laura Cesati; Vittorio Carreri; Nicola Principi

Book ID: 119893972
Publisher: BioMed Central
Year: 2007
Tongue: English
Weight: 552 KB
Volume: 8
Category: Article
ISSN: 1465-9921
DOI: 10.1186/1465-9921-8-12

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity, safety and tolerability

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants

✍ Susanna Esposito; Lorenza Pugni; Samantha Bosis; Alice Proto; Laura Cesati; Ciro 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Safety and immunogenicity of fully liqui

Safety and immunogenicity of fully liquid DTaP5-IPV-Hib pediatric combination vaccine (Pediacel®) compared to DTaP3-HBV-IPV/Hib (Infanrix® Hexa) when coadministered with heptavalent pneumococcal conjugate vaccine (PCV7) as a booster at 11–18 months of age: A phase III, modified double-blind, randomized, controlled, multicenter study

✍ Reinhard Berner; Florence Boisnard; Stéphane Thomas; Grace Mwawasi; Donna Reynol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Immunogenicity and safety of fully liqui

Immunogenicity and safety of fully liquid DTaP5-IPV-Hib compared with DTaP3-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months of age: A phase III, single-blind, randomised, controlled, multicentre study

✍ Emmanuel Grimprel; Jacek Wysocki; Florence Boisnard; Stéphane Thomas; Grace Mwaw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Safety and immunogenicity of a DTaP-IPVV

Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age

✍ Jacek J. Pietrzyk; Jacek Wysocki; Jerzy Pejcz; Andrzej Galaj; Ewa Majda-Stanisla 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 395 KB